bf/NASDAQ:HZNP_icon.png

COM:HORIZONTHERAPEUTICS

Horizon Therapeutics plc

  • Stock

USD

Last Close

116.30

14/11 21:00

Volume Today

23.92M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
net income
-149.00M
-
-263.60M
76.91%
39.53M
115.00%
-166.83M
522.02%
-410.53M
146.07%
-74.19M
81.93%
573.02M
872.40%
389.80M
31.98%
534.49M
37.12%
521.48M
2.43%
depreciation and amortization
9.31M
-
34.01M
265.30%
138.34M
306.78%
221.84M
60.35%
283.42M
27.76%
275.73M
2.71%
237.16M
13.99%
279.45M
17.83%
353.75M
26.59%
390.39M
10.36%
deferred income tax
68.09M
-
-7.52M
111.04%
-180.55M
2,302.20%
-65.56M
63.69%
-132.23M
101.69%
-64.49M
51.23%
-565.54M
776.92%
-33.45M
94.08%
-101.02M
201.96%
49.81M
149.31%
stock based compensation
5.01M
-
13.20M
163.22%
83.55M
533.07%
113.02M
35.27%
125.02M
10.62%
114.86M
8.13%
91.22M
20.59%
146.63M
60.75%
219.09M
49.42%
182.10M
16.88%
change in working capital
-7.17M
-
14.06M
296.08%
1.13M
91.96%
135.77M
11,914.78%
145.99M
7.53%
-144.16M
198.75%
-2.50M
98.27%
-345.68M
13,743.61%
-61.74M
82.14%
-11.98M
80.60%
accounts receivables
-12.49M
-
-46.18M
269.73%
-124.77M
170.16%
-67.50M
45.90%
-61.83M
8.40%
-59.70M
3.45%
56.17M
194.09%
-251.17M
547.20%
34.80M
113.85%
-43.46M
224.89%
inventory
-3.43M
-
7.17M
309.37%
12.22M
70.31%
67.63M
453.64%
108.37M
60.23%
10.28M
90.51%
-3.27M
131.79%
-21.45M
556.40%
1.27M
105.91%
56.12M
4,329.52%
accounts payables
3.91M
-
9.38M
140.10%
-8.36M
189.12%
32.06M
483.46%
-16.52M
151.52%
-4.59M
72.20%
-8.72M
89.92%
16.02M
283.60%
-12.20M
176.16%
122.23M
1,102.15%
other working capital
4.84M
-
43.69M
802.79%
122.04M
179.36%
103.56M
15.14%
115.97M
11.97%
-90.15M
177.74%
-46.67M
48.23%
-89.07M
90.83%
-85.61M
3.88%
-146.88M
71.57%
other non cash items
87.56M
-
237.40M
171.12%
112.16M
52.76%
131.23M
17.00%
268.54M
104.64%
86.79M
67.68%
92.97M
7.13%
118.94M
27.93%
90.70M
23.75%
126.03M
38.96%
net cash provided by operating activities
-54.29M
-
27.55M
150.75%
194.17M
604.80%
369.46M
90.28%
280.21M
24.16%
194.54M
30.57%
426.33M
119.15%
555.69M
30.34%
1.04B
86.30%
1.26B
21.50%
investments in property plant and equipment
-1.20M
-
-3.50M
192.15%
-7.16M
104.46%
-15.73M
119.83%
-4.33M
72.45%
-16.77M
286.96%
-17.86M
6.48%
-199.85M
1,019.18%
-126.17M
36.87%
-126.28M
0.09%
acquisitions net
-35M
-
-224.22M
540.63%
-1.02B
355.96%
-1.36B
32.66%
-97.85M
92.79%
-262.31M
-
-2.85B
984.72%
-3.12M
99.89%
purchases of investments
-71.81M
-
-13.31M
-
-24.67M
85.28%
-9.24M
62.56%
sales maturities of investments
107.40M
-
-30M
-
-49.57M
65.24%
4.63M
109.35%
other investing activites
63K
-
-1.12M
-
-3.88M
245.72%
564K
114.54%
44.42M
7,776.60%
41.40M
-
51.57M
24.57%
net cash used for investing activites
-36.13M
-
-227.72M
530.19%
-995.05M
336.96%
-1.38B
38.27%
-101.62M
92.61%
27.65M
127.21%
-17.86M
164.58%
-464.07M
2,498.82%
-2.99B
545.18%
-134.00M
95.52%
debt repayment
-64.84M
-
-299M
-
-4M
98.66%
-1.62B
40,365.42%
-845.75M
47.75%
-2.15B
154.29%
-1.74M
99.92%
-12M
590.05%
-16M
33.33%
common stock issued
6.64M
-
475.69M
-
8.61M
-
326.79M
3,695.51%
919.79M
181.46%
30.32M
-
common stock repurchased
-992K
-
-250.08M
-
dividends paid
other financing activites
124.92M
-
1.27B
-
661.07M
47.77%
1.68B
153.83%
820.54M
51.10%
1.53B
86.87%
-13.47M
100.88%
1.48B
11,104.77%
-112.20M
107.57%
net cash used provided by financing activities
66.72M
-
338.29M
407.05%
1.44B
326.41%
657.07M
54.45%
58.41M
91.11%
-16.60M
128.41%
-290.45M
1,650.10%
904.58M
411.44%
1.47B
62.52%
-347.96M
123.67%
effect of forex changes on cash
99K
-
213K
115.15%
-790K
470.89%
-1.21M
53.16%
5.32M
539.34%
-1.38M
125.96%
-107K
92.25%
7.24M
6,870.09%
-10.61M
246.41%
-2.45M
76.89%
net change in cash
-23.61M
-
138.33M
685.96%
640.81M
363.26%
-350.56M
154.71%
242.31M
169.12%
204.22M
15.72%
117.92M
42.26%
1.00B
750.94%
-499.32M
149.76%
773.43M
254.90%
cash at beginning of period
104.09M
-
80.48M
22.68%
218.81M
171.88%
859.62M
292.86%
509.06M
40.78%
757.90M
48.88%
962.12M
26.95%
1.08B
12.26%
2.08B
92.91%
1.58B
23.97%
cash at end of period
80.48M
-
218.81M
171.88%
859.62M
292.86%
509.06M
40.78%
751.37M
47.60%
962.12M
28.05%
1.08B
12.26%
2.08B
92.91%
1.58B
23.97%
2.36B
48.82%
operating cash flow
-54.29M
-
27.55M
150.75%
194.17M
604.80%
369.46M
90.28%
280.21M
24.16%
194.54M
30.57%
426.33M
119.15%
555.69M
30.34%
1.04B
86.30%
1.26B
21.50%
capital expenditure
-1.20M
-
-3.50M
192.15%
-7.16M
104.46%
-15.73M
119.83%
-4.33M
72.45%
-16.77M
286.96%
-17.86M
6.48%
-199.85M
1,019.18%
-126.17M
36.87%
-126.28M
0.09%
free cash flow
-55.48M
-
24.05M
143.34%
187.01M
677.62%
353.73M
89.15%
275.87M
22.01%
177.77M
35.56%
408.48M
129.77%
355.84M
12.89%
909.10M
155.48%
1.13B
24.47%

All numbers in USD (except ratios and percentages)